Skip to main content
. 2022 Jul 27;13(10):3000–3012. doi: 10.7150/jca.74930

Table 1.

Baseline characteristics of study participants

Variable Characteristics
Age (years)
< 65 201 (72.0%)
≥ 65 78 (28.0%)
Sex
Men 249 (89.2%)
Women 30 (10.8%)
Site of the primary tumor
Tongue 113 (40.5%)
Buccal mucosa 85 (30.5%)
Gingiva 34 (12.2%)
Retromolar trigone 18 (6.5%)
Mouth floor 13 (4.7%)
Lip 11 (3.9%)
Hard palate 5 (1.7%)
AJCC stage
I 52 (18.6%)
II 38 (13.6%)
III 45 (16.1%)
IV 144 (51.7%)
Tumor size (T classification)
T1 70 (25.1%)
T2 52 (18.6%)
T3 44 (15.8%)
T4 113 (40.5%)
Nodal metastasis (N classification)
N0 179 (64.2%)
N1 30 (10.8%)
N2 55 (19.7%)
N3 15 (5.3%)
PNI 70 (25.1%)
ENE 55 (19.7%)
Cancer cell differentiation
W-D/M-D 248 (88.9%)
P-D 31 (11.1%)
Surgical margin
≥ 5 mm 206 (73.8%)
< 5 mm 73 (26.2%)
DOI ≥ 10 mm 133 (47.7%)
CCI
0 145 (52.0%)
1 82 (29.4%)
≥ 2 52 (18.6%)
Personal Habits
Cigarette Smoking 231 (82.8%)
Betel nut chewing 222 (79.6%)
Alcohol consumption 187 (67.0%)
Treatment
Surgery only 134 (48.0%)
Surgery + RT 39 (14.0%)
Surgery + CRT 106 (38.0%)
Laboratory results
WBC (X103/μL), median (IQR) 7.70 (6.30-9.70)
Neutrophil (X103/μL), median (IQR) 4.80 (3.59-6.44)
Lymphocyte (X103/μL), median (IQR) 2.01 (1.58-2.59)
CRP (mg/dL), median (IQR) 0.36 (0.13-1.52)
Albumin (g/dL), median (IQR) 4.43 (4.10-4.68)
CALLY index, median (IQR) 2.51 (0.52-7.45)